Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:08 AM
Ignite Modification Date:
2025-12-25 @ 12:08 AM
NCT ID:
NCT02473458
Eligibility Criteria:
Inclusion Criteria:
* Symptoms of acute ischemic stroke
* ROSIER score higher than 2
* Confirmation of ischemic brain damage in CT scan
Exclusion Criteria:
* Clinically relevant preexisting neurological deficit or previous CVA
* Primary intracerebral hemorrhage
* Coma (level of consciousness more than 2 in NIHSS scale).
* Negative swallow test
* Patients undergoing hemicraniectomy
* History of epilepsy
* Clinical seizure at onset of stroke
* Systolic BP is \>160 mmHg, diastolic BP\>110 at onset of stroke (if a rise in blood pressure occurred in the course of study it was controlled according to medical guidelines)
* Atrial fibrillation or other tachy/bradyarrythmias at time of allocation or in the middle of intervention
* Ejection Fraction less than 45%
* Potassium less than 4 mEq/dl at onset of stroke
* Malignancy or premalignant state within 5 years
* Myocardial infarction in previous month
* Significant kidney disease (creatinine higher than 1.8 mg/dl)
* Significant liver disease (Bilirubin \> 20 mmoll/L)
* Significant lung disease (FEV1 \< 1.5 L, pO2 \< 70 in room air, pCO2 \> 45)
* Psychiatric illness requiring hospital admission
* Warfarin intake
* Digoxin intake
* Pregnancy
* Breast feeding
* Inability to have follow/up
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
85 Years
Study:
NCT02473458
Study Brief:
Protocol Section:
NCT02473458